<DOC>
	<DOCNO>NCT00286676</DOCNO>
	<brief_summary>This pilot study . We treat 10 HIV-infected adult ( 1/2 lipoatrophy ) GH depot one year . Results compare data 10 HIV patient ( 1/2 lipoatrophy ) , treat Nutropin AQ subcutaneously . The primary endpoint study determine effect GH depot body weight lean tissue mass ( LTM ) . The secondary endpoint document change : 1 ) whole body protein turnover ( WBPT ) , 2 ) gluconeogenesis , 3 ) bone mineral density marker bone turnover , 4 ) fat distribution ( lipoatrophy ) , 5 ) thymus size , 6 ) T-cell subset , 7 ) TNF-µ level . Adverse event , glucose intolerance edema , monitor every visit .</brief_summary>
	<brief_title>The Use Nutropin Depot HIV-Infected Adult Males</brief_title>
	<detailed_description>Patients recruit HIV clinic University Texas Southwestern Medical School Veterans Administration Hospital direct invitation Dr. Margolis ( adult HIV clinic director University director NIH-ACTG ) . We recruit 20 HIV-infected adult male treat stable protease inhibitor therapy regimen past 6 month . One half subject evidence lipoatrophy ( defined ACTG29 ) . Each subject baseline ( BL ) measure make , start GH depot subcutaneous AQ . Patients follow every two week first six week , every three month remainder study . Study parameter measure include ( also see flow chart appendix ) : - Baseline , 3 , 6 12 month : OGTT , testosterone level , whole body protein turnover , hepatic glucose production gluconeogenesis measure , DXA scan ( measure lean tissue mass bone density ) , bone mineral marker , rest energy expenditure , calorie count , T cell subset , TNF µ level . - Every 3 month : IGF-1 ( obtain every 2 week first 6 week ) , body weight , post-prandial glucose level . - Baseline , 6 12 months- CT scan measurement thymus size</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>adult male ≥ 18 year age mild moderate lipoatrophy stable protease inhibitor therapy least six month . Concurrent suprainfection acute illness define fever bacterial culture malignancy females diabetes mellitus CNS tumor .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2006</verification_date>
</DOC>